Sperlich, Johannes M.
Grimbacher, Bodo
Soetedjo, Veronika
Workman, Sarita
Burns, Siobhan O.
Lowe, David M.
Hurst, John R.
Article History
Received: 13 April 2021
Accepted: 9 December 2021
First Online: 11 January 2022
Declarations
:
: Johannes M Sperlich: no conflicts of interest; Bodo Grimbacher: Professor Grimbacher is funded by the Deutsche Forschungsgemeinschaft (GR1617/14–1/iPAD; SFB1160/2_B5; RESIST–EXC 2155–Project ID 390874280; and CIBSS–EXC-2189–Project ID 390939984) and the BMBF (GAIN 01GM1910A). Veronika Soetedjo: no conflicts of interest; Sarita Workman: no conflicts of interest; Siobhan O Burns: no conflicts of interest; David M Lowe: Dr. Lowe has received travel and subsistence costs for unpaid consultancy work from CSL Behring, has participated in an advisory board for Merck, and has received research grants from UCL/UCLH Biomedial Research Centre, Bristol Myers Squibb, LifeArc, MRC (UK) and the British Society for Antimicrobial Chemotherapy, all outside the submitted work; John R Hurst: no conflicts of interest.
: Patients were recruited from the joint Immunology-Respiratory service at the Royal Free Hospital, London, UK. All participants provided written, informed consent in accordance with the Declaration of Helsinki and ethical approval NRES committee London (REC 04/Q0501/119).
: Not applicable.